Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Dec 15;376(Pt 3):765–771. doi: 10.1042/BJ20030932

Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism.

Andelko Hrzenjak 1, Sasa Frank 1, Xingde Wo 1, Yonggang Zhou 1, Theo Van Berkel 1, Gert M Kostner 1
PMCID: PMC1223821  PMID: 14510638

Abstract

Lp(a) [lipoprotein (a)] is a highly atherogenic plasma lipoprotein assembled from low-density lipoprotein and the glycoprotein apolipoprotein (a). The rate of Lp(a) biosynthesis correlates significantly with plasma Lp(a) concentrations, whereas the fractional catabolic rate does not have much influence. So far, little is known about Lp(a) catabolism. To study the site and mode of Lp(a) catabolism, native or sialidase-treated Lp(a) was injected into hedgehogs or ASGPR (asialoglycoprotein receptor)-knockout (ASGPR-) mice or wild-type (ASGPR+) mice, and the decay of the plasma Lp(a) concentration was followed. COS-7 cells were transfected with high- (HL-1) and low-molecular-mass ASGPR subunits (HL-2), and binding and degradation of intact or desialylated Lp(a) were measured. In hedgehogs, one of the few species that synthesize Lp(a), most of the Lp(a) was taken up by the liver, followed by kidney and spleen. Lp(a) and asialo-Lp(a) were catabolized with apparent half-lives of 13.8 and 0.55 h respectively. Asialo-orosomucoide increased both half-lives significantly. In mice, the apparent half-life of Lp(a) was 4-6 h. Catabolism of native Lp(a) by wild-type mice was significantly faster compared with ASGPR- mice and there was a significantly greater accumulation of Lp(a) in the liver of ASGPR+ mice compared with ASGPR- mice. The catabolism of asialo-Lp(a) in ASGPR- mice was 8-fold faster when compared with native Lp(a) in wild-type mice. Transfected COS-7 cells expressing functional ASGPR showed approx. 5-fold greater binding and 2-fold faster degradation of native Lp(a) compared with control cells. Our results for the first time demonstrate a physiological function of ASGPR in the catabolism of Lp(a).

Full Text

The Full Text of this article is available as a PDF (158.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Argraves K. M., Kozarsky K. F., Fallon J. T., Harpel P. C., Strickland D. K. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest. 1997 Nov 1;100(9):2170–2181. doi: 10.1172/JCI119753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bijsterbosch M. K., Van Berkel T. J. Lactosylated high density lipoprotein: a potential carrier for the site-specific delivery of drugs to parenchymal liver cells. Mol Pharmacol. 1992 Feb;41(2):404–411. [PubMed] [Google Scholar]
  3. Craig W. Y., Neveux L. M., Palomaki G. E., Cleveland M. M., Haddow J. E. Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem. 1998 Nov;44(11):2301–2306. [PubMed] [Google Scholar]
  4. Dieplinger H., Utermann G. The seventh myth of lipoprotein(a): where and how is it assembled? Curr Opin Lipidol. 1999 Jun;10(3):275–283. doi: 10.1097/00041433-199906000-00010. [DOI] [PubMed] [Google Scholar]
  5. Edelstein C., Shapiro S. D., Klezovitch O., Scanu A. M. Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology. J Biol Chem. 1999 Apr 9;274(15):10019–10023. doi: 10.1074/jbc.274.15.10019. [DOI] [PubMed] [Google Scholar]
  6. Evans R. W., Shpilberg O., Shaten B. J., Ali S., Kamboh M. I., Kuller L. H. Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial. J Clin Epidemiol. 2001 Jan;54(1):51–57. doi: 10.1016/s0895-4356(00)00260-2. [DOI] [PubMed] [Google Scholar]
  7. Fadden Andrew J., Holt Oliver J., Drickamer Kurt. Molecular characterization of the rat Kupffer cell glycoprotein receptor. Glycobiology. 2003 Apr 2;13(7):529–537. doi: 10.1093/glycob/cwg068. [DOI] [PubMed] [Google Scholar]
  8. Fless G. M., ZumMallen M. E., Scanu A. M. Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). J Biol Chem. 1986 Jul 5;261(19):8712–8718. [PubMed] [Google Scholar]
  9. Frank S., Hrzenjak A., Blaschitz A., Dohr G., Kostner G. M. Role of various tissues in apo(a) fragmentation and excretion of fragments by the kidney. Eur J Clin Invest. 2001 Jun;31(6):504–512. doi: 10.1046/j.1365-2362.2001.00811.x. [DOI] [PubMed] [Google Scholar]
  10. Frank S., Hrzenjak A., Kostner K., Sattler W., Kostner G. M. Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice. Biochim Biophys Acta. 1999 Apr 19;1438(1):99–110. doi: 10.1016/s1388-1981(99)00044-x. [DOI] [PubMed] [Google Scholar]
  11. Frank S., Krasznai K., Durovic S., Lobentanz E. M., Dieplinger H., Wagner E., Zatloukal K., Cotten M., Utermann G., Kostner G. M. High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein. Biochemistry. 1994 Oct 11;33(40):12329–12339. doi: 10.1021/bi00206a041. [DOI] [PubMed] [Google Scholar]
  12. Garner B., Merry A. H., Royle L., Harvey D. J., Rudd P. M., Thillet J. Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance. J Biol Chem. 2001 Apr 6;276(25):22200–22208. doi: 10.1074/jbc.M102150200. [DOI] [PubMed] [Google Scholar]
  13. Gaw A., Boerwinkle E., Cohen J. C., Hobbs H. H. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest. 1994 Jun;93(6):2526–2534. doi: 10.1172/JCI117263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harkes L., Jürgens G., Holasek A., van Berkel T. J. In vivo studies on the binding sites for lipoprotein (a) on parenchymal and non-parenchymal rat liver cells. FEBS Lett. 1988 Jan 18;227(1):27–31. doi: 10.1016/0014-5793(88)81406-6. [DOI] [PubMed] [Google Scholar]
  15. Ishibashi S., Hammer R. E., Herz J. Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. J Biol Chem. 1994 Nov 11;269(45):27803–27806. [PubMed] [Google Scholar]
  16. Koschinsky M. L., Côté G. P., Gabel B., van der Hoek Y. Y. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem. 1993 Sep 15;268(26):19819–19825. [PubMed] [Google Scholar]
  17. Kostner G. M., Gavish D., Leopold B., Bolzano K., Weintraub M. S., Breslow J. L. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 1989 Nov;80(5):1313–1319. doi: 10.1161/01.cir.80.5.1313. [DOI] [PubMed] [Google Scholar]
  18. Kostner G. M., Ibovnik A., Holzer H., Grillhofer H. Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard. J Lipid Res. 1999 Dec;40(12):2255–2263. [PubMed] [Google Scholar]
  19. Kostner K. M., Maurer G., Huber K., Stefenelli T., Dieplinger H., Steyrer E., Kostner G. M. Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):905–911. doi: 10.1161/01.atv.16.8.905. [DOI] [PubMed] [Google Scholar]
  20. Kostner Karam M., Kostner Gerhard M. Lipoprotein(a): still an enigma? Curr Opin Lipidol. 2002 Aug;13(4):391–396. doi: 10.1097/00041433-200208000-00006. [DOI] [PubMed] [Google Scholar]
  21. Krempler F., Kostner G. M., Bolzano K., Sandhofer F. Turnover of lipoprotein (a) in man. J Clin Invest. 1980 Jun;65(6):1483–1490. doi: 10.1172/JCI109813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kronenberg F., Kronenberg M. F., Kiechl S., Trenkwalder E., Santer P., Oberhollenzer F., Egger G., Utermann G., Willeit J. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation. 1999 Sep 14;100(11):1154–1160. doi: 10.1161/01.cir.100.11.1154. [DOI] [PubMed] [Google Scholar]
  23. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  24. Liu R., Saku K., Kostner G. M., Hirata K., Zhang B., Shiomi M., Arakawa K. In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits. Eur J Clin Invest. 1993 Sep;23(9):561–565. doi: 10.1111/j.1365-2362.1993.tb00966.x. [DOI] [PubMed] [Google Scholar]
  25. Maartmann-Moe K., Berg K. Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor. Clin Genet. 1981 Nov;20(5):352–362. doi: 10.1111/j.1399-0004.1981.tb01047.x. [DOI] [PubMed] [Google Scholar]
  26. Marcovina S. M., Albers J. J., Gabel B., Koschinsky M. L., Gaur V. P. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995 Feb;41(2):246–255. [PubMed] [Google Scholar]
  27. McLean J. W., Tomlinson J. E., Kuang W. J., Eaton D. L., Chen E. Y., Fless G. M., Scanu A. M., Lawn R. M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987 Nov 12;330(6144):132–137. doi: 10.1038/330132a0. [DOI] [PubMed] [Google Scholar]
  28. März W., Beckmann A., Scharnagl H., Siekmeier R., Mondorf U., Held I., Schneider W., Preissner K. T., Curtiss L. K., Gross W. Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. FEBS Lett. 1993 Jul 5;325(3):271–275. doi: 10.1016/0014-5793(93)81087-g. [DOI] [PubMed] [Google Scholar]
  29. Niemeier A., Willnow T., Dieplinger H., Jacobsen C., Meyer N., Hilpert J., Beisiegel U. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):552–561. doi: 10.1161/01.atv.19.3.552. [DOI] [PubMed] [Google Scholar]
  30. Pittman R. C., Carew T. E., Glass C. K., Green S. R., Taylor C. A., Jr, Attie A. D. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J. 1983 Jun 15;212(3):791–800. doi: 10.1042/bj2120791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Reblin T., Niemeier A., Meyer N., Willnow T. E., Kronenberg F., Dieplinger H., Greten H., Beisiegel U. Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. J Lipid Res. 1997 Oct;38(10):2103–2110. [PubMed] [Google Scholar]
  32. Roos P. H., Kolb-Bachofen V., Schlepper-Schäfer J., Monsigny M., Stockert R. J., Kolb H. Two galactose-specific receptors in the liver with different function. FEBS Lett. 1983 Jul 4;157(2):253–256. doi: 10.1016/0014-5793(83)80556-0. [DOI] [PubMed] [Google Scholar]
  33. Sandholzer C., Hallman D. M., Saha N., Sigurdsson G., Lackner C., Császár A., Boerwinkle E., Utermann G. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet. 1991 Apr;86(6):607–614. doi: 10.1007/BF00201550. [DOI] [PubMed] [Google Scholar]
  34. Teng B., Blumenthal S., Forte T., Navaratnam N., Scott J., Gotto A. M., Jr, Chan L. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem. 1994 Nov 25;269(47):29395–29404. [PubMed] [Google Scholar]
  35. Troyer H., Babich E. A hematoxylin and eosin-like stain for glycol methacrylate embedded tissue sections. Stain Technol. 1981 Jan;56(1):39–43. doi: 10.3109/10520298109067273. [DOI] [PubMed] [Google Scholar]
  36. White A. L., Lanford R. E. Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes. J Biol Chem. 1994 Nov 18;269(46):28716–28723. [PubMed] [Google Scholar]
  37. van Berkel T. J., Kruijt J. K., Spanjer H. H., Nagelkerke J. F., Harkes L., Kempen H. J. The effect of a water-soluble tris-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes. J Biol Chem. 1985 Mar 10;260(5):2694–2699. [PubMed] [Google Scholar]
  38. von Eckardstein A., Schulte H., Cullen P., Assmann G. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol. 2001 Feb;37(2):434–439. doi: 10.1016/s0735-1097(00)01126-8. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES